Results 211 to 220 of about 406,416 (358)
Abstract Syndrome‐specific International Classification of Diseases, 10th Revision (ICD‐10) codes have the potential to improve identification of patients for precision therapies, clinical trials, and research, yet their real‐world uptake is not well characterized.
Émile Moura Coelho da Silva +15 more
wiley +1 more source
Discovery of a First-in-Class Murine Double Minute 2-Recruiting Positive Transcription Elongation Factor B PROTAC Degrader With Selective Antitumor Activity. [PDF]
Guan X +16 more
europepmc +1 more source
Graphical abstract for the systematic literature review. Abstract Objective Dravet syndrome (DS) places tremendous burden on caregivers owing to the extent of required assistance and impact on daily living, as well as the risk to the individual with DS of premature mortality from sudden unexpected death in epilepsy and morbidity associated with ...
Adam Strzelczyk +8 more
wiley +1 more source
Cyclin-E/A/CDK1/2 Kinetic Landscapes Drive Cell Cycle Phase-Specific Progression and Guide Cyclin-E Degradation Strategy. [PDF]
Zhang W +5 more
europepmc +1 more source
Abstract Objective Current pharmacotherapy for temporal lobe epilepsy (TLE) is limited to symptomatic treatment and leaves approximately one third of patients with inadequate seizure control. Discovering disease‐modifying targets is an unmet clinical need. We have previously identified senescent cells (SCs) as one such target. Many drugs that eliminate
David J. McFall +3 more
wiley +1 more source
Emerging Strategies to Inhibit the G1/S Transition for Cancer Therapy. [PDF]
Rubin SM, Sage J, Skotheim JM.
europepmc +1 more source
卵巣内におけるSerum- and glucocorticoid-regulated kinase (SGK)による細胞内pH上昇とcyclin B-Cdk1活性化を介したヒトデ卵第一減数分裂の制御機構[学位論文内容の要旨/学位論文審査の要旨/日本語要旨/外国語要旨] [PDF]
絵奈子 細田
openalex

